A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

Clinical trial NCT00852397 · TERMINATED

Trial details

NCT number: NCT00852397
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2009-04-01
Primary completion: 2010-12-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.